Big Pharma Split Corp.
PRM.TO · TSX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CA$14,926 | CA$16,731 | CA$22,005 | CA$18,915 |
| - Cash | CA$1,031 | CA$204 | CA$819 | CA$1,430 |
| + Debt | CA$11,573 | CA$10,297 | CA$9,854 | CA$14,863 |
| Enterprise Value | CA$25,469 | CA$26,824 | CA$31,040 | CA$32,347 |
| Revenue | CA$1,849 | CA$312 | CA$3,926 | CA$5,359 |
| % Growth | 493.1% | -92.1% | -26.7% | – |
| Gross Profit | CA$1,533 | CA$312 | CA$3,507 | CA$5,003 |
| % Margin | 82.9% | 100% | 89.3% | 93.4% |
| EBITDA | CA$21 | -CA$138 | CA$3,146 | CA$4,854 |
| % Margin | 1.2% | -44.1% | 80.1% | 90.6% |
| Net Income | -CA$539 | -CA$140 | CA$3,146 | CA$4,854 |
| % Margin | -29.1% | -44.8% | 80.1% | 90.6% |
| EPS Diluted | -0.47 | -0.53 | 1.58 | 3.27 |
| % Growth | 11.3% | -133.5% | -51.7% | – |
| Operating Cash Flow | -CA$1,296 | CA$11,858 | CA$1,128 | -CA$9,000 |
| Capital Expenditures | CA$0 | -CA$0 | CA$0 | CA$0 |
| Free Cash Flow | -CA$1,296 | CA$11,858 | CA$1,128 | -CA$9,000 |